02 June 2012

Angioplasty and Stent



Angioplasty and Stenting of the Great Vessels
J. Bayne Selby, Jr., MD
Angioplasty and Stenting of the Great Vessels.ppt

The Biomedical Engineers
The Biomedical Engineers.ppt

Coronary Stent
Megan French
Coronary Stent.ppt

Coronary Stents
Courtney Medeiros
Coronary Stents.ppt

Coronary Angiography
Mark East, MD, FACC
Coronary Angiography.ppt

Clinical Evaluation of Angioplasty Versus Stenting
Andrew Rendoff, PA-S, Richard D. Muma, PhD, MPH, PA-C
Clinical Evaluation of Angioplasty Versus Stenting.ppt

Renal Artery Stenosis – The Good, The Bad and The Different
Rick Stouffer MD
Renal Artery Stenosis.ppt

Stents for Coronary Applications
Krishna Rangavajhula
Stents for Coronary Applications.ppt

Clinical and Manufacturing Aspects of Medical Devices
Ganesh Iyer
Clinical and Manufacturing Aspects of Medical Devices.ppt

ACC/AHA Guidelines for Percutaneous Coronary Intervention
Ryan Tsuda, MD
ACC/AHA Guidelines for Percutaneous Coronary Intervention.ppt

Renovascular Disease
Michael Shomaker, MD
Renovascular Disease.ppt

Aspirin Resistance in Cardiovascular Disease
Scott A. McKee, M.D.
Aspirin Resistance in Cardiovascular Disease.ppt

The Stent Market: Global and the United States
Stephan Bosshard, Maritza Rodriguez
The Stent Market: Global and the United States.ppt

Angiography and Arteriography
Angiography and Arteriography.ppt

Peripheral Artery Occlusive Disease
Peripheral Artery Occlusive Disease.ppt

Atherosclerotic coronary vascular disease
Atherosclerotic coronary vascular disease.ppt

Alteration in Cardiac Perfusion & Output
Rose Bianchi, RN, DNSc
Alteration in Cardiac Perfusion & Output.ppt
600 scholarly article free access


  1. Device closure of post-myocardial infarction ventricular septal defect three weeks after coronary angioplasty.
  2. Aortic dissection, a complication during successful angioplasty of chronic total occlusion of the right coronary artery, was treated conservatively.
  3. Percutaneous transluminal renal angioplasty with stent is effective for blood pressure control and renal function improvement in atherosclerotic renal artery stenosis patients.
  4. Improvement of Astatikopsia (Riddoch's phenomenon) after correction of vertebral stenoses with angioplasty.
  5. Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
  6. Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting.
  7. Clinical outcomes of infrapopliteal angioplasty in patients with critical limb ischemia.
  8. Acquired (post-angioplasty) coronary ventricular fistula draining into left ventricle aneurysm.
  9. Medical Treatment Versus Angioplasty for Isolated Ostial Diagonal Stenoses: A Comparative Clinical Follow-up.
  10. Primary angioplasty for acute myocardial infarction with an anomalous origin of right coronary artery: Report of one case.
  11. Endovascular revascularization of symptomatic infrapopliteal arteriosclerotic occlusive disease: comparison of atherectomy and angioplasty.
  12. Primary angioplasty programme in Greece.
  13. Subintimal renal artery angioplasty in a case of renal artery stenosis leading to malignant hypertension.
  14. Renal artery rupture during complicated recovery from angioplasty to treat renal stenosis.
  15. Hypertension without renovascular stenosis: a rare case of abdominal aorta coarctation treated with percutaneous transluminal angioplasty.
  16. Plaque-Stabilizing Statin Therapy Prior to Percutaneous Transluminal Angioplasty and Stenting.
  17. Plaque-Stabilizing Statin Therapy Prior to Percutaneous Transluminal Angioplasty and Stenting.
  18. Angioplasty compared to thrombolysis as the initial reperfusion therapy in acute myocardial infarction.
  19. Acute myocardial infarction mortality in Chile: thrombolysis or angioplasty.
  20. Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty.
  21. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.
  22. Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty.
  23. Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance.
  24. Primary angioplasty in Northern Galicia: care changes and results following implementation of the PROGALIAM protocol.
  25. Laparoscopic nephrectomy, ex vivo angioplasty, and renal autotransplant for a renal artery aneurysm: a case report.
  26. Renal insufficiency and vascular complications after primary angioplasty via femoral route. Impact of vascular closure devices use.
  27. Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty.
  28. Composed angioplasty of the multilevel right common and internal carotid artery stenoses with implantation stents with used of proximal and distal protection system.
  29. Primary percutaneous angioplasty, thrombolysis and conservative treatment in low-risk patients with ST-elevation myocardial infarction: effects on short- and long-term mortality.
  30. Analysis of potential cost-savings after introduction of drug-eluting balloon angioplasty for in-stent restenosis or small vessel disease.
  31. Diffuse unilateral pediatric arteriopathy: successful treatment with repeated angioplasty.
  32. Percutaneous transluminal pulmonary angioplasty for distal-type chronic thromboembolic pulmonary hypertension.
  33. Iatrogenic acute coronary dissection during coronary angioplasty for in-stent restenosis: role of intravascular ultrasound in diagnosis and treatment.
  34. Long-term outcome of angioplasty or stent placement for stenosis of the cavernous or petrous portion of the internal carotid artery.
  35. Propensity score analysis of 10-year long-term outcome after bypass surgery or plain old balloon angioplasty in patients with metabolic syndrome.
  36. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension.
  37. Medical angioplasty - Hope and expectations: An optimistic overview.
  38. Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.
  39. 30-day outcome after percutaneous coronary angioplasty in nonagenarians: feasibility and specific considerations in different clinical settings.
  40. Predictive value of SYNTAX score in risk stratification of patients undergoing unprotected left main coronary artery angioplasty.
  41. Percutaneous coronary angioplasty in women: clinical, procedural and prognostic features.
  42. A blunt chest trauma causing left anterior descending artery dissection and acute myocardial infarction treated by deferred angioplasty.
  43. Comparison of clinical outcome of infrapopliteal angioplasty between Korean diabetic and non-diabetic patients with critical limb ischemia.
  44. Effect of ketamine pretreatment for anaesthesia in patients undergoing percutaneous transluminal balloon angioplasty with continuous remifentanil infusion.
  45. Does percutaneous transluminal renal artery angioplasty improve blood pressure control and renal function in patients with atherosclerotic renal artery stenosis?
  46. Periprocedural complication rate of carotid endarterectomy versus carotid angioplasty and stenting: a retrospective study and review of the literature.
  47. Use of embolic capture angioplasty for the treatment of occluded superficial femoral artery segments.
  48. Coronary angioplasty versus CABG: review of randomized trials.
  49. The primary patency of percutaneous transluminal angioplasty in hemodialysis patients with vascular access failure.
  50. Treatment of pacemaker-induced superior vena cava syndrome by balloon angioplasty and stenting.
  51. Diagnostic accuracy of adenosine stress cardiovascular magnetic resonance following acute ST-segment elevation myocardial infarction post primary angioplasty.
  52. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
  53. Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist?
  54. Rapid desensitisation of patients with aspirin allergy who undergo coronary angioplasty.
  55. Patch angioplasty and neo-ostium creation for intramural left coronary artery.
  56. Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease.
  57. Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?
  58. Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
  59. The impact of plaque characterization assessed by intravascular ultrasound on myocardial perfusion after primary angioplasty in patients With ST-segment elevation myocardial infarction.
  60. Influence of platelet reactivity on outcome of patients with acute myocardial infarction undergoing primary angioplasty.
  61. Surgical angioplasty and unroofing technique for intramural coronary anomaly.
  62. Serum levels after everolimus-stent implantation and paclitaxel-balloon angioplasty in an infant with recurrent pulmonary vein obstruction after repaired total anomalous pulmonary venous connection.
  63. Percutaneous angioplasty of the left renal artery in a patient with acute infarction of the left kidney with persistent occlusion of the right renal artery treated with angiotensin converting enzyme inhibitor.
  64. Placement of dual double-J stents following high-pressure balloon angioplasty for treatment of ureter-ileum bladder anastomosis stricture.
  65. Percutaneous transluminal angioplasty and stenting of the vertebral artery ostium with balloon-mounted bare coronary stents.
  66. Percutaneous retrieval of entrapped partially inflated broken coronary angioplasty balloon by modified Fogarty technique.
  67. Percutaneous coronary vein angioplasty for severe spasm of the posterolateral vein during bi-ventricular pacing.
  68. The efficiency of cutting balloon angioplasty in the treatment of in-stent restenosis.
  69. Gender-related benefit of transport to primary angioplasty: is it equal?
  70. Cerebral artery restenosis following transluminal balloon angioplasty for vasospasm after subarachnoid hemorrhage.
  71. Simultaneous carotid angioplasty and intracraneal thrombectomy in acute stroke.
  72. Primary angioplasty in a high-volume tertiary center in Turkey: in-hospital clinical outcomes of 1625 patients.
  73. The impact of chronic kidney disease on in-hospital clinical outcomes in patients undergoing primary percutaneous angioplasty for ST-segment elevation myocardial infarction.
  74. Angioplasty in acute middle cerebral artery stroke due to atrial fibrillation selected by CT perfusion: a case report.
  75. Critical limb ischaemia in a diabetic population from an Asian Centre: angiographic pattern of disease and 3-year limb salvage rate with percutaneous angioplasty as first line of treatment.
  76. Four hour ambulation after angioplasty is a safe practice method.
  77. Analysis of reperfusion delay in patients with acute myocardial infarction treated with primary angioplasty based on first medical contact and time of presentation.
  78. Thrombus contribution to very late restenosis of bare-metal stent treated by excimer laser angioplasty: in vivo assessment with optical coherence tomography.
  79. The comparison a 16-year follow-up results of balloon angioplasty for aortic coarctation in children of different age groups: a single-center experience.
  80. Transluminal angioplasty of transplanted renal artery stenosis: a review of the literature for its safety and efficacy.
  81. Safety and efficacy of transluminal balloon angioplasty using a compliant balloon for severe cerebral vasospasm after an aneurysmal subarachnoid hemorrhage.
  82. Emergency surgical intervention after unsuccessful percutaneous transluminal angioplasty and stenting of aortic coarctation.
  83. Successful primary coronary angioplasty improves early and long-term outcomes in ST segment elevation acute coronary syndromes in patients above 80 years of age.
  84. Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry.
  85. Clinical effectiveness of percutaneous angioplasty for acute and chronic mesenteric ischemia: a six case series.
  86. Treatment of benign ureteral stricture by double J stents using high-pressure balloon angioplasty.
  87. Indications for balloon angioplasty of the renal arteries: to revisit?.
  88. Spontaneous pneumopericardium after coronary angioplasty.
  89. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?
  90. Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report.
  91. Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome.
  92. Primary angioplasty in women with ST-elevation myocardial infarction: in-hospital and long-term clinical results.
  93. Effectiveness of cutting balloon angioplasty for a calcified coronary lesion. evaluation by optical coherence tomography and intravascular ultrasound.
  94. Surgical reconstruction of the left main coronary artery with patch-angioplasty.
  95. Carotid artery stenting without angioplasty and cerebral protection: a single-center experience with up to 7 years' follow-up.
  96. Cutting balloon angioplasty for the treatment of multivessel coronary artery disease in a patient with unstable angina.
  97. Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention Through the Addition of a "Compassionate Use" Variable to the National Cardiovascular Data Registry CathPCI Dataset A Study From the Massachusetts Angioplasty Registry.
  98. Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty.
  99. High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study.
  100. Increased vascular injury reduces the degree of intimal hyperplasia following angioplasty in rabbits.
  101. The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
  102. One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction.
  103. Percutaneous transluminal angioplasty with stenting for renal artery stenosis.
  104. Comparative efficacy analysis of an aspiration device before primary angioplasty in patients with acute myocardial infarction: a single-center experience.
  105. Angioplasty versus surgery: meta-analyses or registries?
  106. Spontaneous pneumopericardium after coronary angioplasty.
  107. Myocardial blood volume and coronary resistance during and after coronary angioplasty.
  108. Noninvasive Positive Pressure Ventilation against Reperfusion Pulmonary Edema following Percutaneous Transluminal Pulmonary Angioplasty.
  109. Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review.
  110. Routine early coronary angioplasty after thrombolysis in acute ST-elevation myocardial infarction: lysis is not the final step.
  111. Letter by Fresco regarding article "Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish Acute Myocardial Infarction 2 trial".
  112. Six-year clinical follow-up after treatment of diffuse in-stent restenosis with cutting balloon angioplasty followed by intracoronary brachytherapy with liquid rhenium-188-filled balloon via transradial approach.
  113. Angioplasty and stenting of totally occluded common carotid artery at the chronic stage.
  114. Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial.
  115. Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty.
  116. Early outcomes after carotid angioplasty with stenting performed by neurologists.
  117. Is angioplasty able to become the gold standard of treatment beyond bypass surgery for patients with multivessel coronary artery disease? Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI(PCI-Side).
  118. Time course of early changes in plasma markers of collagen turnover following percutaneous transluminal coronary angioplasty.
  119. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study.
  120. Congenital pulmonary vein stenosis in an adult patient treated with transcatheter balloon angioplasty.
  121. Small coronary vessel angioplasty: outcomes and technical considerations.
  122. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
  123. Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery.
  124. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies.
  125. Carotid revascularisation using angioplasty and stent in 134 consecutive cases in a reference hospital: a risky technique?.
  126. Impact of obesity on results after primary angioplasty in patients with ST segment elevation acute myocardial infarction.
  127. Treatment of carotid artery disease: endarterectomy or angioplasty?
  128. Letter by Chalmers regarding article "Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial".
  129. Primary angioplasty in the very elderly - how old is too old?
  130. Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
  131. Brooks MM, Chung SC, Helmy T, Hillegass WB, Escobedo J, Melsop KA, Massaro EM, McBane RD, Hyde P, Hlatky MA; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.
  132. Radial artery angioplasty after perforation during diagnostic cardiac catheterisation.
  133. The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia.
  134. Iatrogenic subtotal stenosis of the right subclavian artery treated with percutaneous transluminal angioplasty.
  135. Successful Percutaneous Renal Artery Angioplasty and Stenting for Acute Oliguric Renal Failure in a Solitary Functioning Kidney Caused by Takayasu's Arteritis.
  136. Remote Ischemic Conditioning in Patients With Myocardial Infarction Treated With Primary Angioplasty: Impact on Left Ventricular Function Assessed by Comprehensive Echocardiography and Gated Single-Photon Emission CT.
  137. Cardiovascular devices; reclassification of certain percutaneous transluminal coronary angioplasty (PTCA) catheters. Final rule.
  138. Coronary vein angioplasty to facilitate implantation of left ventricular lead.
  139. Relationship between Tpeak-Tend interval and coronary artery stenosis and effects of percutaneous transluminal coronary angioplasty on Tpeak-Tend.
  140. Value of NT-ProBNP level and echocardiographic parameters in ST-segment elevation myocardial infarction treated by primary angioplasty: relationships between these variables and their usefulness as predictors of ventricular remodeling.
  141. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
  142. Characterization of vascular strain during in-vitro angioplasty with high-resolution ultrasound speckle tracking.
  143. Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial.
  144. Actual Role of Platelet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in Acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin.
  145. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
  146. Screening, diagnosis, and treatment of renal artery stenosis by percutaneous transluminal renal angioplasty with stenting.
  147. Comparison of plain balloon and cutting balloon angioplasty for the treatment of restenosis with drug-eluting stents vs bare metal stents.
  148. Thrombosuction for procedural acute thrombosis during high-risk carotid angioplasty--a case report.
  149. Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
  150. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease.
  151. Long-term comparison of balloon angioplasty with provisional stenting versus routine stenting in patients with non-ST-elevation acute coronary syndrome.
  152. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
  153. Indications for imaging and percutaneous angioplasty of renal artery stenosis in patients with arterial hypertension. Statement of the Polish Society of Hypertension, Polish Society of Nephrology and Polish Cardiac Society.
  154. Cerebral haemodynamics during carotid angioplasty with flow interruption. The correlation between oximetry and transcranial Doppler ultrasonography.
  155. Angioplasty confirmation of the spontaneous resolution of two low-flow carotid-cavernous fistulas.
  156. Changes in perfusion-weighted magnetic resonance imaging after carotid angioplasty with stent.
  157. Immediate and long-term results of coronary angioplasty in patients aged 80 years and older.
  158. Angiographic CT after intravenous contrast agent application: A noninvasive follow-up tool after intracranial angioplasty and stenting.
  159. Angioplasty versus medical treatment in oligosymptomatic patients: is it time to stop it?.
  160. Staged endovascular treatment of left common carotid artery large aneurysm with Gore-Hemobahn stent-graft after right common carotid artery stenosis angioplasty.
  161. Primary angioplasty and later elective multivessel stenting in a patient with dextrocardia: a case report and literature review.
  162. Stent graft versus balloon angioplasty for failing dialysis access grafts: a long-awaited advance in the treatment of permanent hemodialysis access.
  163. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
  164. Carotid stent removal of symptomatic plaque protrusion after carotid angioplasty stenting.
  165. Five-year clinical results of coronary angioplasty with drug-eluting stents. National initiative in strategic innovation, iNOS.
  166. The effectiveness of microballoon angioplasty in treating middle cerebral artery occlusion beyond the bifurcation.
  167. Percutaneous transluminal angioplasty in pediatric patients with Takayasu arteritis: comparison of initial and long- term results of interventions on aorta and non-aortic vessels.
  168. Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study.
  169. General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
  170. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
  171. Balloon angioplasty in a 1200-gram premature infant with critical aortic coarctation.
  172. Local hemodynamic changes caused by main branch stent implantation and subsequent virtual side branch balloon angioplasty in a representative coronary bifurcation.
  173. Five-year retrograde transpopliteal angioplasty results compared with antegrade angioplasty.
  174. Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction.
  175. In-hospital delay to primary angioplasty for patients with ST-elevated myocardial infarction between cardiac specialized hospitals and non-specialized hospitals in Beijing, China.
  176. Stent graft or balloon angioplasty alone for dialysis-access grafts.
  177. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
  178. Gastrointestinal bleeding in patients undergoing primary angioplasty for acute myocardial infarction: incidence, risk factors and prognosis.
  179. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
  180. Unprotected left main angioplasty in nonagenarians: clinical characteristics, procedural features and outcome: a case series study.
  181. A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization.
  182. Symptomatic carotid vasospasm caused by a distal-protection device during stent angioplasty of the right internal carotid artery.
  183. Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular adverse remodelling.
  184. Angioplasty on an infarct-related anomalous right coronary artery arising from posterior coronary sinus.
  185. Complete atrioventricular block complicating acute anterior myocardial infarction can be reversed with acute coronary angioplasty.
  186. Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.
  187. Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
  188. Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
  189. Guide wire fracture during percutaneous transluminal coronary angioplasty: possible causes and management.
  190. Retrograde angioplasty: an option for total coronary artery occlusions.
  191. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial.
  192. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
  193. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
  194. Management of anastomotic stenosis after lower extremity bypass surgery with cutting balloon angioplasty.
  195. Living with heart disease after angioplasty: A qualitative study of patients who have been successful or unsuccessful in multiple behavior change.
  196. Radial access for concomitant coronary, subclavian and renal artery angioplasty: one case report.
  197. Impaired cognitive function due to cerebellar infarction and improvement after stent-assisted angioplasty for intracranial vertebral artery stenosis--case report.
  198. Renal artery rupture following cutting balloon angioplasty for fibromuscular dysplasia: a case report.
  199. A dual (brachial and contralateral femoral) approach for subintimal angioplasty of long ilio-femoral occlusive disease including the iliac ostium.
  200. Stent graft versus balloon angioplasty for failing dialysis-access grafts.
  201. Paffenbarger Physical Activity Questionnaire as an additional tool in clinical assessment of patients with coronary artery disease treated with angioplasty.
  202. ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial.
  203. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials.
  204. Bidirectional precordial ST changes during angioplasty to right coronary artery.
  205. Results of primary angioplasty in a reference center: in-hospital outcomes.
  206. Delayed carotid wallstent shortening resulting in restenosis following successful carotid artery angioplasty and stenting.
  207. External carotid artery angioplasty and stenting followed by superficial temporal artery to middle cerebral artery anastomosis.
  208. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
  209. Returning patients after primary percutaneous coronary angioplasty: the (re) TRANSFER AMI.
  210. Effect of race on the clinical outcomes in the bypass angioplasty revascularization investigation trial.
  211. Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
  212. Impact of thrombus aspiration on myocardial tissue reperfusion and left ventricular functional recovery and remodeling after primary angioplasty.
  213. Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST).
  214. Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents.
  215. The first generation of angioplasty.
  216. In-hospital mortality and complications after coronary angioplasty, City of Rio de Janeiro, Southeastern Brazil.
  217. Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty.
  218. Impact of biplane versus single-plane imaging on radiation dose, contrast load and procedural time in coronary angioplasty.
  219. Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit.
  220. Effectiveness of the hugging balloon technique in coronary angioplasty for a heavy, encircling, calcified coronary lesion.
  221. Primary angioplasty vs. thrombolysis: the end of the controversy?
  222. Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with or without subsequent brachytherapy: the effect on blood pressure in patients with renovascular hypertension.
  223. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.
  224. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
  225. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: a 10-year single-center experience.
  226. Repair of coronary artery perforation following angioplasty using TachoSil patches.
  227. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
  228. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
  229. Collateral arterial formation in a severed brachial artery causing difficult transradial access during percutaneous transluminal coronary angioplasty.
  230. Primary angioplasty to left main coronary artery in an octogenarian with acute myocardial infarction and cardiogenic shock.
  231. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
  232. Creating synergy in our health system: The challenges of primary angioplasty.
  233. Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting.
  234. HOTLINE II, TRIANA, elderly AMI patients fare better with angioplasty.
  235. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
  236. Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
  237. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials.
  238. A simple ECG marker for the detection of coronary restenosis after successful coronary angioplasty.
  239. Stent-assisted percutaneous angioplasty for extra-cranial carotid disease:experience at Singapore General Hospital.
  240. Routine early angioplasty after fibrinolysis.
  241. Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
  242. Suprarenal stricture of the inferior vena cava with massive iliocaval and distal thromboses successfully treated with catheter-directed thrombectomy, thrombolysis and angioplasty.
  243. The role of myocardial perfusion imaging in the evaluation of patients undergoing percutaneous transluminal coronary angioplasty.
  244. Broncho-angioplasty surgery in the treatment of lung cancer.
  245. Safety and efficacy of transradial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience.
  246. Indication for percutaneous coronary angioplasty.
  247. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction).
  248. Neuropsychological sequelae of carotid angioplasty with stent placement: correlation with ischemic lesions in diffusion weighted imaging.
  249. Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device.
  250. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.Circulation. 2010 Mar 2;121(8):e228.
  251. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial.
  252. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial.
  253. Axillary vein rupture after angioplasty.
  254. Ventricular fibrillation occurring two hours after successful angioplasty in non-ST-segment elevation acute coronary syndrome.
  255. Percutaneous transluminal angioplasty for stenosis of the posterior cerebral artery in progressive stroke. Case report.
  256. Effect of percutaneous transluminal coronary angioplasty on QT dispersion and heart rate variability parameters.
  257. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
  258. Coronary artery bypass surgery, angioplasty and long term anti-platelet treatment in a type B hemophilia patient.
  259. Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction.
  260. Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease?
  261. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
  262. Interleukin-1b and interleukin-1 receptor inhibitor gene cluster polymorphisms in patients with coronary artery disease after percutaneous angioplasty or coronary artery bypass grafting.
  263. Restenosis after renal artery angioplasty and stenting: incidence and risk factors.
  264. Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).
  265. Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial.
  266. Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF.
  267. Exercise training decreases the size and alters the composition of the neointima in a porcine model of percutaneous transluminal coronary angioplasty (PTCA).
  268. Implantation of the left ventricular pacemaker lead after successful balloon angioplasty for coronary vein stenosis: a report of two cases.
  269. Routine early angioplasty after fibrinolysis for acute myocardial infarction.
  270. The unlocking of the coronary arteries: origins of angioplasty. A short historical review of arterial dilatation from Dotter to the creative Gruentzig.
  271. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up.
  272. Long-term durability of percutaneous transluminal angioplasty in patients with symptomatic middle cerebral artery stenosis.
  273. Cutting balloon angioplasty for aortic coarctation.
  274. Percutaneous transluminal coronary angioplasty for postoperative left coronary artery stenosis following surgical reconstruction of congenital atresia of the left main coronary artery.
  275. Twenty-two years angiographic and clinical follow-up of the first patient treated with intracoronary stent placement for acute vessel closure following percutaneous transluminal coronary angioplasty.
  276. Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience.
  277. Primary angioplasty and diurnal variations.
  278. Renal ostial angioplasty and stenting. Part 2: pitfalls and complications.
  279. Change in cerebral perfusion after carotid angioplasty with stenting is related to cerebral vasoreactivity: a study using dynamic susceptibility-weighted contrast-enhanced MR imaging and functional MR imaging with a breath-holding paradigm.
  280. Combined infrainguinal reconstruction and infrapopliteal intraluminal angioplasty for limb salvage in critical limb ischemia.
  281. Retinal artery embolization during carotid angioplasty and carotid artery stenting: case report.
  282. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.
  283. Subintimal angioplasty: an alternative to open surgery of the lower limb chronic artery occlusion.
  284. Effects of short- and long-term efficacy of percutaneous transluminal renal angioplasty with or without intravascular brachytherapy on regression of left ventricular hypertrophy in patients with renovascular hypertension.
  285. Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis.
  286. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
  287. Clinical outcomes with off-pump coronary surgery after angioplasty with stent.
  288. Role of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty.
  289. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h.
  290. Short femoropopliteal arterial stenoses: is cutting balloon angioplasty the solution?
  291. Correlation of heart rate turbulence to coronary lesions and its changes following percutaneous transluminal coronary angioplasty.
  292. Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
  293. Percutaneous transluminal angioplasty and stent placement in acute vessel occlusion: evaluation of new methods for interventional stroke treatment.
  294. 'It got right to the spot' The patient experience of primary angioplasty: a qualitative study.
  295. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.
  296. Changes in heart rate variability caused by coronary angioplasty depend on the localisation of coronary lesions.
  297. Coronary stent immobilization during angioplasty by transcoronary ventricular pacing via a guidewire.
  298. Hemodynamic index of atheromatous renal artery stenosis for angioplasty.
  299. Angioplasty and stenting of the renal artery in a patient undergoing coronary angiography due to suspected acute coronary syndrome.
  300. Negligible contribution of coronary adventitial fibroblasts to neointimal formation following balloon angioplasty in swine.
  301. Renal ostial angioplasty and stenting. Part 1: the routine procedure.
  302. Prognostic factors and outcomes in young chinese patients with acute myocardial infarction undergoing primary coronary angioplasty.
  303. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis.
  304. Enoxaparin vs. non-fractionated heparin in primary angioplasty of acute myocardial infarction.
  305. Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy.
  306. The New York State Primary Angioplasty Registry and procedural volume.
  307. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty.
  308. Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction.
  309. Effect of different sessions of cardiac rehabilitation on exercise capacity in patients with percutaneous transluminal coronary angioplasty.
  310. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty.
  311. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial.
  312. Predictors and time-related impact of distal embolization during primary angioplasty.
  313. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial.
  314. Primary percutaneous angioplasty. An analysis of reperfusion delays, their determining factors and their prognostic implications.
  315. Milrinone infusion: a therapeutic option in coronary vasospasm after primary percutaneous transluminal coronary angioplasty.
  316. Stent angioplasty of narrowed portocaval shunt in Budd Chiari syndrome: a case report.
  317. Use of percutaneous angioplasty to facilitate implantation of the left ventricular pacemaker lead for CRT.
  318. An unexpected finding during planned primary percutaneous coronary angioplasty.
  319. Importance of preserving coronary branches during angioplasty, assessed by cardiac resonance.
  320. Percutaneous transluminal coronary angioplasty in a patient with three small vessel disease: the role of intravascular ultrasound.
  321. Initial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.
  322. Letter - Re: Primary carotid stenting without angioplasty.
  323. Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty: ANIN Myocardial Infarction Registry.
  324. Left ventricular performance and exercise capacity in patients aged 65 years and older treated by primary coronary angioplasty or conservatively for acute myocardial infarction--a one-year follow-up.
  325. Percutaneous transluminal angioplasty of suture-mediated closure device-related femoral artery stenosis or occlusive disease.
  326. Light-dark variations in neopterin serum levels in patients with ST-segment elevation acute coronary syndrome undergoing primary angioplasty.
  327. Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. An open randomized study "Prague-5".
  328. Angioplasty as early revascularization in acute myocardial infarction.
  329. Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis.
  330. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
  331. Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT).
  332. Comparison of early and long-term impact of percutaneous transluminal renal artery angioplasty alone or with brachytherapy on renal function in patients with reno-vascular hypertension.
  333. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
  334. Urgent intracranial angioplasty after combined systemic and intra-arterial thrombolysis in acute stroke. An initial experience in indonesia.
  335. Use of a small-caliber angioplasty balloon for the management of an impassable choledochocholedochal anastomotic biliary stricture.
  336. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction.
  337. Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly.
  338. A modified technique for carotid cannulation via the transfemoral approach, during angioplasty and stent placement.
  339. Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
  340. A case of successful thrombectomy with coronary angioplasty balloon in a totally occluded right coronary artery.
  341. Embolization of the contralateral renal artery by stent during renal angioplasty.
  342. Can patients with significant renal artery stenosis who underwent renal angioplasty be monitored postprocedure in the general ward instead of the high dependency unit?
  343. Effect of nattokinase on restenosis after percutaneous transluminal angioplasty of the abdominal artery in rabbits.
  344. Extensive patch angioplasty of the left main ostial stenosis using a rhombic-shaped pulmonary autograft.
  345. Percutaneous transluminal angioplasty in the treatment of stenosis of arteriovenous fistulae for hemodialysis.
  346. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
  347. Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.
  348. Dialysis access venous stenoses: treatment with balloon angioplasty--1- versus 3-minute inflation times.
  349. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
  350. Reperfusion strategies in acute ST-segment elevation myocardial infarction: acute angioplasty may be feasible for the majority of U.S. citizens.
  351. Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study.
  352. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
  353. Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty.
  354. Elective and primary angioplasty at hospitals without on-site surgery versus with on-site surgery: results from a national registry.
  355. Images in cardiovascular medicine. Placement of a left ventricular pacing lead after balloon angioplasty of a coronary vein stenosis: coronary sinus obstruction as a complication after mitral valve operation.
  356. Safety of magnetic resonance imaging after coronary angioplasty with stent.
  357. DNA double-strand breaks after percutaneous transluminal angioplasty.
  358. Transradial approach for coronary angioplasty in Chinese elderly patients.
  359. Feeling fixed and its contribution to patient satisfaction with primary angioplasty: a qualitative study.
  360. Myocardial perfusion assessed by contrast echocardiography correlates with angiographic perfusion parameters in patients with a first acute myocardial infarction successfully treated with angioplasty.
  361. Endothelial-dependent vasoconstriction in the infarct-related artery early after myocardial infarction is smaller following primary angioplasty than thrombolytic therapy.
  362. Thrombus fragmentation using iliac balloon angioplasty in a patient with massive pulmonary embolism.
  363. Analysis of serial coronary artery flow patterns early after primary angioplasty: new insights into the dynamics of the microcirculation.
  364. Angioplasty strategies in ST-segment-elevation myocardial infarction: part II: intervention after fibrinolytic therapy, integrated treatment recommendations, and future directions.
  365. Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention.
  366. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study.
  367. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
  368. Smokers versus non-smokers undergoing percutaneous transluminal coronary angioplasty: The impact of clinical and procedural characteristics on in-hospital mortality.
  369. Early predictors of adverse left ventricular remodelling after myocardial infarction treated by primary angioplasty.
  370. Percutaneous coronary angioplasty in elderly patients: Assessment of in-hospital outcomes.
  371. Thirty years of coronary angioplasty.
  372. No-reflow phenomenon: Achilles' heel of primary coronary angioplasty in acute myocardial infarction.
  373. Commentary to the article: Di Mario C, Dudek D, Piscione F, et al.; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008; 371: 559-68.
  374. Occult carotid artery disease in patients who have undergone coronary angioplasty.
  375. Successful RF ablation of permanent VT in a patient with acute coronary syndrome treated by complex angioplasty and stent implantation.
  376. A rare coronary anomaly detected during primary percutaneous coronary angioplasty: totally occluded left main coronary artery originating from the right coronary artery.
  377. Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network.
  378. High-pressure balloon angioplasty of coronary sinus vein.
  379. Acute and long-term outcome of unprotected left main coronary angioplasty compared to the anticipated surgical risk.
  380. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease.
  381. Angioplasty of the renal artery as a trigger for acute anti-phospholipid syndrome.
  382. Carotid Stenting without Angioplasty and without Protection: The Advantages of a Less Invasive Procedure.
  383. Takayasu's arteritis treated by percutaneous transluminal angioplasty with stenting in the descending aorta.
  384. The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea acute myocardial infarction registry.
  385. Number of patients receiving angioplasty is rising, heart attack audit shows.
  386. Predictors of death and stroke after carotid angioplasty and stenting: a subgroup analysis of the Pro-CAS data.
  387. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience.
  388. Long-term (up to 20 years) results of percutaneous balloon angioplasty of recurrent aortic coarctation without use of stents.
  389. Is coronary vein angioplasty necessary to provide cardiac resynchronization in selected patients? A case report.
  390. Very late clinical progression of patients with acute myocardial infarction submitted to primary angioplasty.
  391. Unusual use of a standard percutaneous transluminal coronary angioplasty balloon catheter to the rescue.
  392. Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction.
  393. Rescue retrieval of AngioGuard embolic capture system after failure of capture sheath retrieval in carotid angioplasty and stenting.
  394. Cutting balloon angioplasty for carotid artery in-stent stenosis supported by three-dimensional rotational angiography with automated vessel analysis software.
  395. Angioscopic observation after coronary angioplasty for chronic coronary occlusion comparison with severe stenotic lesion.
  396. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
  397. Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias.
  398. Impact of impaired renal function and diabetes on long-term prognosis in patients undergoing primary angioplasty for acute coronary syndrome.
  399. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis.
  400. Sinus node dysfunction following effective angioplasty of the right coronary artery.
  401. Left main coronary artery occlusion with myocardial infarction in a cocaine user. Successful angioplasty with a drug-eluting stent.
  402. Severe acute mitral regurgitation resolved via angioplasty.
  403. Provisional reverse "mini-crush" technique for bifurcation angioplasty.
  404. Coronary aneurysm formation after primary coronary angioplasty.
  405. Short- and mid-term results of balloon angioplasty in the treatment of aortic coarctation in children.
  406. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty.
  407. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial.
  408. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review.
  409. Frugal coronary angioplasty, still an option after 30 years.
  410. Angioplasty, stenting and thrombectomy to correct left main coronary stem obstruction by a bioprosthetic aortic valve.
  411. My history of carotid angioplasty and stenting.
  412. Early and late outcomes of percutaneous transluminal angioplasty of cephalad arteries.
  413. Angioplasty in critical limb ischaemia: one-year limb salvage results.
  414. Female gender is an independent predictor of in-hospital mortality in patients with ST segment elevation acute myocardial infarction treated with primary angioplasty.
  415. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
  416. Recurrent intracranial stenosis induced by the Wingspan stent: comparison with balloon angioplasty alone in a single patient.
  417. Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease.
  418. Risk factors and neurological consequences of syncopes induced by internal carotid artery angioplasty.
  419. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.
  420. Superior vena cava thrombosis treated by angioplasty and stenting in a cirrhotic patient with peritoneovenous shunt.
  421. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
  422. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
  423. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial.
  424. Asymptomatic coronary fistula disclosed during angioplasty performed due to acute coronary syndrome.
  425. Repeat angioplasty of the left anterior descending coronary artery due to restenosis. How many times could we do it?.
  426. Recanalization of occluded modified Blalock-Taussig shunt with balloon angioplasty and intraarterial streptokinase.
  427. Stent placement versus angioplasty improves patency of arteriovenous grafts and blood flow of arteriovenous fistulae.
  428. Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results.
  429. Double balloon angioplasty for unstentable large-caliber right coronary stenosis.
  430. Myocardial salvage in STEMI patients treated with primary coronary angioplasty as demonstrated by myocardial SPECT.
  431. The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
  432. Retrograde angioplasty in chronic total occlusion.
  433. Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty.
  434. Value of Doppler ultrasound hemodynamics in the assessment of renal artery stenosis in transplanted kidneys: an assessment of patients after percutaneous transluminal angioplasty.
  435. Percutaneous transluminal angioplasty of failing hemodialysis grafts and fistulae.
  436. Transluminal angioplasty and stenting for intracranial vertebrobasilar occlusive lesions in acute stroke patients.
  437. Doppler waveform pattern changes in a patient with primary Budd-Chiari syndrome before and after angioplasty.
  438. Preventing restenosis after angioplasty: a multistage approach.
  439. Anterior cerebral artery angioplasty for intracranial atherosclerosis.
  440. Effectiveness and safety of routine primary angioplasty in patients aged > or =85 years with acute myocardial infarction.
  441. Percutaneous transluminal angioplasty of the subclavian arteries.
  442. Post-percutaneous coronary angioplasty atheroembolization--a feared iatrogenic complication.
  443. Impact of the time to reperfusion on early outcomes in patients with acute myocardial infarction undergoing primary angioplasty.
  444. Comparison of primary balloon angioplasty with bailout stenting strategy to primary coronary stenting strategy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
  445. Carotid angioplasty and stenting.
  446. In vivo thrombogenicity of embolic protection systems for angioplasty and stenting.
  447. Percutaneous angioplasty in the diabetic foot.
  448. Simple new method for making a rat carotid artery post-angioplasty stenosis model.
  449. Letter by Golledge regarding article, "Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting".
  450. Changing health behaviors to improve health outcomes after angioplasty: a randomized trial of net present value versus future value risk communication.
  451. Tool/tissues interaction modeling for transluminal angioplasty simulation.
  452. The effect of femoral and popliteal percutaneous transluminal balloon angioplasty on patients' quality of life.
  453. Unintended stent extraction from a coronary artery during bifurcation coronary angioplasty.
  454. Second acute coronary syndrome due to acute occlusion of previously non-infarct related coronary artery in the patient treated with primary angioplasty--not only stenosis matters.
  455. Clinical and electroencephalographic features of carotid sinus syncope induced by internal carotid artery angioplasty.
  456. Balloon angioplasty of native coarctation and comparison of patients younger and older than 3 months.
  457. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up.
  458. Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results.
  459. An unexpected finding during planned primary percutaneous coronary angioplasty.
  460. Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction.
  461. Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
  462. Optimization and audit of radiation dose during percutaneous transluminal coronary angioplasty.
  463. Angioplasty with stenting in a case of recurrent cerebral ischemia due to middle cerebral artery stenosis.
  464. Time delay in primary angioplasty: how relevant is it?
  465. Comparison of the incidence of acute coronary event after balloon angioplasty vs. stenting in native coronary arteries.
  466. An angioplasty of chronic total occlusion of left anterior descending coronary artery with contralateral visualisation technique.
  467. Towards an understanding of the role of rescue angioplasty for failed fibrinolysis: comparison of the MERLIN, RESCUE and REACT trials.
  468. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.
  469. Percutaneous transluminal angioplasty to left internal mammary artery grafts: immediate and long-term clinical outcomes.
  470. Delayed presentation of rupture after venous angioplasty.
  471. QT interval dispersion changes according to the vessel involved during percutaneous coronary angioplasty.
  472. Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry.
  473. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis.
  474. Triple wire technique for removal of fractured angioplasty guidewire.
  475. Carotid stenting without use of balloon angioplasty and distal protection devices: preliminary experience in 100 cases.
  476. Stent rupture with subsequent balloon catheter failure and entrapment under stent during elective angioplasty at the right coronary artery.
  477. Coronary artery bypass grafting in a patient after percutaneous left main angioplasty with DES stent implantation.
  478. Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes.
  479. Cardiovascular medicine update 2007: perioperative risk, carotid angioplasty, drug-eluting stents, stronger statins.
  480. Comparison of classical and non-classical cardiovascular risk factors influencing the patency of native arteriovenous fistulas after percutaneous transluminal angioplasty therapy among haemodialysis patients.
  481. Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome.
  482. Stent-supported angioplasty of a residual coronary artery dissection following replacement of the ascending aorta for acute type A aortic dissection.
  483. Late patency of the left internal thoracic artery graft in patients with and without previous successful percutaneous transluminal coronary angioplasty.
  484. Revascularization of dysfunctioning myocardium: differential prognostic effects of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients with three-vessel disease and mostly viable myocardium.
  485. Surgical removal of entrapped and broken percutaneous transluminal coronary angioplasty balloon catheter.
  486. Systemic inflammatory response syndrome: incidence and influence on outcome in acute myocardial infarction treated with primary angioplasty.
  487. Comparative assessment of ECG dynamics in myocardial infarction according to reperfusion therapy approach (primary and facilitated coronary angioplasty) and timing of the procedure.
  488. Angioplasty stenting with Sirolimus (rapamycin) eluting stents in type 2 diabetic patients.
  489. Percutaneous angioplasty and stenting of subclavian arteries before surgical coronary revascularization in a patient with an aberrant right subclavian artery.
  490. Importance of preserving coronary branches during angioplasty, assessed by cardiac resonance.
  491. Subintimal angioplasty for superficial femoral artery occlusions: first experience in Kaunas University of Medicine Hospital.
  492. Prolonged successful resuscitation with simultaneous complex angioplasty of the left anterior descending coronary artery in acute myocardial infarction complicated by cardiogenic shock--a case report.
  493. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
  494. Impact of contemporary emergency percutaneous coronary angioplasty for acute myocardial infarction on length of hospital stay.
  495. Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow.
  496. Percutaneous transluminal angioplasty of the popliteal artery without the use of stents: A review of 116 consecutive procedures.
  497. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).
  498. Quality of life after surgical myocardial revascularization, angioplasty or medical treatment.
  499. Accordion phenomenon: a iatrogenic pitfall during coronary angioplasty.
  500. A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with acute myocardial infarction: angiographic measures in relation to clinical outcome.
  501. A bleeding kiss: intramural haematoma secondary to balloon angioplasty.
  502. Drug-eluting stents in primary angioplasty long-term clinical outcomes.
  503. Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty.
  504. Sugarcane biopolymer patch in femoral artery angioplasty on dogs.
  505. Coronary angiography and angioplasty in diabetic patients.
  506. Renal angioplasty with stent using CO2 as contrast medium: report of one case.
  507. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.
  508. Renal artery stenosis in swine: feasibility of MR assessment of renal function during percutaneous transluminal angioplasty.
  509. Percutaneous transluminal angioplasty using a pull-through technique for hepatic arterial occlusion at the time of port-catheter implantation.
  510. Basilar artery stent angioplasty for symptomatic intracranial athero-occlusive disease: complications and late midterm clinical outcomes.
  511. Combined use of aspiration catheter and distal embolisation protection device to facilitate angioplasty of a totally occluded saphenous vein graft.
  512. Carotid angioplasty and stent placement after EVA-3S trial.
  513. Role of infrainguinal angioplasty in the treatment of critical limb ischaemia.
  514. Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty.
  515. Case for angioplasty to treat angina.
  516. Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction: a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction.
  517. Hospital case fatality associated with coronary angioplasty in Rio de Janeiro State, Brazil, 1999-2003.
  518. Optical coherence tomography after cutting balloon angioplasty.
  519. Prevention of restenosis: is angioplasty the answer?
  520. Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.
  521. Cerebral hemodynamic changes after carotid angioplasty and stenting.
  522. Primary patency with cutting and conventional balloon angioplasty for different types of hemodialysis access stenosis.
  523. Fibrinolysis may widen the time window for primary angioplasty.
  524. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney.
  525. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial.
  526. Treating iliac artery occlusive disease with subintimal angioplasty.
  527. The relationship between acute phase serum amyloid A (SAA) protein concentrations and left ventricular systolic function in acute myocardial infarction patients treated with primary coronary angioplasty.
  528. Restenosis after coronary angioplasty: pathomechanism and potential targets for therapeutic intervention. Focus on inflammation.
  529. Cardiovascular rehabilitation of patients with ischemic heart disease undergoing medical treatment, percutaneous transluminal coronary angioplasty, and coronary artery bypass grafting.
  530. Perfusion CT to evaluate the effect of transluminal angioplasty on cerebral perfusion in the treatment of vasospasm after subarachnoid hemorrhage.
  531. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
  532. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): prologue to COURAGE.
  533. Benefits of transfer primary angioplasty are durable, so why are we waiting?
  534. Prophylactic angioplasty of failing hemodialysis shunts.
  535. Tibial recanalization with excimer laser angioplasty.
  536. Balloon angioplasty for ductus arteriosus in infant with ductal origin of the left pulmonary artery: combination with nitrogen inhalation therapy.
  537. Time from coronary artery bypass surgery does not affect outcome in patients treated with primary angioplasty for acute saphenous vein graft occlusion.
  538. Restenosis after percutaneous angioplasty: the role of vascular inflammation.
  539. The impact of time-to-balloon on outcomes in patients undergoing modern primary angioplasty for acute myocardial infarction.
  540. The influence of various factors on results of subintimal angioplasty of superficial femoral artery occlusions.
  541. Changes in N-terminal pro B-type natriuretic peptide concentration: comparative study of percutaneous transluminal coronary angioplasty and off-pump coronary artery bypass graft.
  542. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
  543. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
  544. Acute myocardial infarction interventional procedures: primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention, rescue angioplasty, rescue excimer laser.
  545. Carotid angioplasty and stenting under protection. State of the art.
  546. One year follow up of successful coronary angioplasty in non selected patients.
  547. Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis.
  548. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease.
  549. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.
  550. Thyroiditis and iodide mumps following an angioplasty.
  551. Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis.
  552. Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty.
  553. Stenting and angioplasty of the symptomatic chronically occluded carotid artery.
  554. Commentary to the articles: SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368: 1239-47. Mas JL, Chatellier G, Beyssen B, et al. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 355: 1660-71.
  555. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
  556. Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting.
  557. Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery--a pilot study.
  558. Impact of cutting balloon angioplasty (CBA) prior to bare metal stenting on restenosis.
  559. Angioplasty of an idiopathic intracranial arterial stenosis.
  560. Primary angioplasty of the right coronary artery in the patient with chronic cardiac insufficiency after myocardial infarction.
  561. Staged percutaneous coronary angioplasty as a therapy of choice in three-vessel coronary disease in a patient with serious contraindications for coronary artery bypass grafting surgery - a case report.
  562. Carotid endarterectomy with internal carotid artery segmental resection, temporary shunt and vein patch angioplasty: early and mid-term results.
  563. A prospective patient observational study of the role of hyperhomocysteinemia in restenosis in patients undergoing infrainguinal angioplasty or bypass procedures.
  564. Coronary angioplasty induced oxidative stress and its relation with metoprolol use and plasma homocysteine levels.
  565. Drive-through angioplasty: is it safe or necessary?
  566. In-hospital and long-term mortality in women with acute myocardial infarction treated by primary angioplasty.
  567. Higher mortality in women undergoing primary angioplasty. Another gender enigma?.
  568. Does cardiac rehabilitation improve quality of life for a man with coronary artery disease who received percutaneous transluminal coronary angioplasty with insertion of a stent?
  569. Using dexmedetomidine to manage patients with cocaine and opioid withdrawal, who are undergoing cerebral angioplasty for cerebral vasospasm.
  570. Salvage of nonmaturing native fistulas by using angioplasty.
  571. Life saving angioplasty of left main coronary artery in a high risk patient.
  572. Successful recanalization by in-stent percutaneous transluminal angioplasty with distal protection for acute carotid stent thrombosis.
  573. Percutaneous Transluminal Coronary Angioplasty of unprotected left main coronary artery in patient with severe left ventricular contractility dysfunction.
  574. Stent angioplasty in aortic arch interruption.
  575. Intracranial angioplasty and stenting: long-term results from a single center.
  576. Percutaneous transluminal angioplasty and stenting for chronic total occlusion of intracranial carotid artery: a case report.
  577. Predictors of left ventricular dysfunction in patients with first acute anterior myocardial infarction undergoing primary angioplasty.
  578. Ebstein's anomaly with coarctation of the aorta and neonatal balloon angioplasty.
  579. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART).
  580. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study.
  581. Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty.
  582. Angioplasty and stenting to correct ostial right coronary artery obstruction by a prosthetic aortic valve.
  583. Images in cardiovascular medicine. Percutaneous transluminal angioplasty for treatment of critical hand ischemia.
  584. Hyperperfusion syndrome after intracranial angioplasty and stent placement.
  585. l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty.
  586. Inflammatory response after coronary angioplasty - mechanisms and significance.
  587. Successful percutaneous angioplasty of renal artery in a patient with severe arterial hypertension and symptoms of hyperaldosteronism: a case report.
  588. Percutaneous angioplasty of chronically occluded coronary arteries: long-term clinical follow-up.
  589. Balloon angioplasty or nitinol stents for peripheral-artery disease.
  590. Transradial rescue angioplasty for failed thrombolysis in acute myocardial infarction: reperfusion with reduced vascular risk.
  591. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
  592. Angioplasty for renovascular hypertension in children: 20-year experience.
  593. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
  594. Subintimal angioplasty in the treatment of chronic lower limb ischemia.
  595. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death.
  596. Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty.
  597. Viewpoint: thrombolysis or angioplasty in the real world: a UK perspective.
  598. Ebstein's anomaly with coarctation of the aorta and neonatal balloon angioplasty.
  599. Stenting of the superficial femoral artery after suboptimal balloon angioplasty: one-year results.
  600. Evolution of the treatment of carotid occlusive disease: indications for carotid angioplasty and stenting versus carotid endarterectomy.
  601. Usefulness of angioplasty in a patient with biopsy-proven giant cell arteritis and severe stenosis of the superior mesenteric artery.

0 comments:

All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP